Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sublingual misoprostol versus manual vacuum aspiration for incomplete miscarriage in Katsina
PACTR202310863957659Not yet recruiting
- Sponsor
- Self
- Start
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of misoprostol in incomplete spontaneous abortion, sponsored by Self. Primary endpoint: Completed uterine evacuation after one week. Planned start Dec 2023; status: not yet recruiting.
02
Drugs
misoprostol
03
Conditions
incomplete spontaneous abortion
Beyond the preview
Go deeper on PACTR202310863957659.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202310863957659.